Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zheng Zhou University, Zheng Zhou, 450052, China.
Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zheng Zhou University, Zheng Zhou, 450052, China.
Placenta. 2023 Jul;138:33-43. doi: 10.1016/j.placenta.2023.05.001. Epub 2023 May 3.
Proliferation, migration and invasion of extravillous trophoblasts (EVTs) play an important role in the progression of preeclampsia (PE). The purpose of this study was to investigate the molecular mechanism by which DNA methylase regulates the transcription level of APLNR and affects the phenotypic function of EVTs.
PE mice model and H/R model in HTR8/Svneo cells were constructed. Clinical samples of normal pregnant women and PE patients were collected. Expression and methylation level of APLNR in vivo and in vitro were detected. ChIP-qPCR was used to detect the binding of DNA methyltransferase at the APLNR promoter. The expression of DNA methyltransferase 1 (DNMT1), NO and eNOS in vitro were detected. EVTs proliferation, migration and invasion in vitro were detected.
In placental tissues or HTR8/Svneo cells of the PE model group, the expression of APLNR was reduced and APLNR methylation level was up-regulated. There was no significant difference in the APLNR expression in placental tissues between normal pregnant women and PE patients. H/R conditions only promote the binding of DNMT1 at the APLNR promoter. DNMT1 interference decreased the enrichment degree of DNMT1 in APLNR promoter region and up-regulated the mRNA and protein levels of APLNR in vivo and in vitro. The activation of APLNR by Elabela (ELA) can promote eNOS transcription, thereby promoting cell proliferation and NO level, while eNOS inhibitor can reverse this effect. DNMT1 down-regulation inhibted APLNR methylation level, promoted eNOS transcription, and promoted EVTs proliferation, migration and invasion, which could be revised by the interference of APLNR.
DNMT1 promotes eNOS transcription by inhibting APLNR methylation level, and promotes EVTs proliferation, migration and invasion, thus providing a new and broad application prospect for PE treatment.
滋养外胚层细胞(EVTs)的增殖、迁移和侵袭在子痫前期(PE)的进展中起着重要作用。本研究旨在探讨 DNA 甲基转移酶如何调节 APLNR 的转录水平,从而影响 EVTs 的表型功能。
构建 PE 小鼠模型和 HTR8/Svneo 细胞中的 H/R 模型。收集正常孕妇和 PE 患者的临床样本。检测体内和体外 APLNR 的表达和甲基化水平。ChIP-qPCR 用于检测 APLNR 启动子处 DNA 甲基转移酶的结合。检测体外 DNA 甲基转移酶 1(DNMT1)、NO 和 eNOS 的表达。检测体外 EVTs 的增殖、迁移和侵袭。
在 PE 模型组胎盘组织或 HTR8/Svneo 细胞中,APLNR 的表达减少,APLNR 甲基化水平上调。正常孕妇和 PE 患者胎盘组织中 APLNR 的表达无明显差异。H/R 条件仅促进 DNMT1 在 APLNR 启动子处的结合。DNMT1 干扰降低了 DNMT1 在 APLNR 启动子区域的富集程度,并上调了体内和体外的 APLNR mRNA 和蛋白水平。Elabela(ELA)对 APLNR 的激活可促进 eNOS 转录,从而促进细胞增殖和 NO 水平,而 eNOS 抑制剂可逆转此作用。DNMT1 下调抑制 APLNR 甲基化水平,促进 eNOS 转录,促进 EVTs 的增殖、迁移和侵袭,APLNR 的干扰可修正此作用。
DNMT1 通过抑制 APLNR 甲基化水平促进 eNOS 转录,促进 EVTs 的增殖、迁移和侵袭,为 PE 的治疗提供了新的广阔应用前景。